Ursolic acid silences CYP19A1/aromatase to suppress gastric cancer growth.

Abstract

INTRODUCTION:

Gastric cancer (GCa) is a malignancy with few effective treatments. Ursolic acid (UA), a bioactive triterpenoid enriched in Hedyotis diffusa Willd, known to suppress GCa without identified target. CYP19A1 (cytochrome P450 family 19A1; also known as aromatase, Ar) was correlated to GCa prognosis. Relatedly, Ar silencers, which halt the expression of Ar exhibited anti-GCa effects in experimental models, are currently being investigated.

METHOD:

The docking simulation score of UA was compared with Ar inhibitors, e.g., letrozole, exemestane, in Ar protein crystallization. Hedyotis diffusa Willd ethanol extract, UA, or 5-fluracil were applied onto AGS, SC-M1, MKN45 GCa cells for cancer inhibition tests. Immunoblot for measuring gene expressions upon drug treatments, or gene knockdown/overexpression. Treatments were also applied in a MKN45 implantation tumor model. A web-based GCa cohort for Ar expression association with prognosis was performed.

RESULT:

The ethanol extracts of Hedyotis diffusa Willd, enrich with UA, exhibited cytotoxic activity against GCa cells. Molecular docking simulations with the 3D Ar structure revealed an excellent fitting score for UA. UA increase cytotoxic, and suppressed colony, in addition to its Ar silencing capacity. Moreover, UA synergistically facilitated 5-FU, (a standard GCa treatment) regimen in vitro. Consistent with those results, adding estradiol did not reverse the cancer-suppressing effects of UA, which confirmed UA acts as an Ar silencer. Furthermore, UA exhibited tumor-suppressing index (TSI) score of 90% over a 6-week treatment term when used for single dosing in xenograft tumor model. In the clinical setting, Ar expression was found to be higher in GCa tumors than normal parental tissue from the TCGA (The Cancer Genome Atlas) cohort, while high Ar expression associated with poor prognosis. Together, the results indicate UA could be used to treat GCa by silencing Ar expression in GCa. Hedyotis diffusa Willd ethanol extract could be an functional food supplements.

• Authors: Wen-Lung Ma, Ning Chang, Yingchun Yu, Yu-Ting Su, Guan-Yu Chen, Wei-Chung Cheng, Yang-Chang Wu, Ching-Chia Li, Wei-Chun Chang, Juan-Cheng Yang
• Journal: Cancer medicine (Cancer Med) Vol. 11 Issue 14 Pg. 2824-2835 (07 2022) ISSN: 2045-7634 [Electronic] United States
• PMID: 35545835 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Chemical References

• Antineoplastic Agents
• Plant Extracts
• Triterpenes
• Ethanol
• Aromatase
• CYP19A1 protein, human
• Fluorouracil

Topics

• Animals
• Antineoplastic Agents (pharmacology)
• Aromatase (genetics)
• Ethanol
• Fluorouracil
• Hedyotis (chemistry)
• Humans
• Molecular Docking Simulation
• Plant Extracts (pharmacology)
• Stomach Neoplasms (drug therapy, genetics)
• Triterpenes (pharmacology)
• Ursolic Acid